121 related articles for article (PubMed ID: 65775)
21. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y
Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169
[TBL] [Abstract][Full Text] [Related]
22. Contact sensitivity to azobenzenearsonate and its inhibition after interaction of sensitized cells with antigen-conjugated cells.
Thomas WR; Smith FI; Walker ID; Miller JF
J Exp Med; 1981 May; 153(5):1124-37. PubMed ID: 6454743
[TBL] [Abstract][Full Text] [Related]
23. Arsonate-specific murine T cell clones. II. Delayed-type hypersensitivity induced by P-azobenzenearsonate-L-tyrosine (ABA-Tyr).
Morita CT; Goodman JW; Lewis GK
J Immunol; 1985 May; 134(5):2894-9. PubMed ID: 2580007
[TBL] [Abstract][Full Text] [Related]
24. Requirements for inducing tolerance of hapten-specific delayed hypersensitivity: epitope density.
Moon MM; Redelman D; Wolvos TA; Bauer DC
J Immunol; 1977 Dec; 119(6):2005-12. PubMed ID: 72114
[TBL] [Abstract][Full Text] [Related]
25. The specificity of tolerance induction in delayed hypersensitivity.
Goldman M; Leskowitz S
J Immunol; 1970 Apr; 104(4):874-7. PubMed ID: 4191858
[No Abstract] [Full Text] [Related]
26. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.
Colvin RB; Dvorak HF
J Immunol; 1975 Jan; 114(1 Pt 2):377-87. PubMed ID: 1090656
[TBL] [Abstract][Full Text] [Related]
27. The regulation of hapten-specific granuloma formation.
Greene MI; Ginsburg CH; Benacerraf B
Clin Immunol Immunopathol; 1982 May; 23(2):275-85. PubMed ID: 6213341
[No Abstract] [Full Text] [Related]
28. Carrier and hapten functions in immune deviation. I. Contrary effects of hapten and carrier on cellular and helper functions of T cells.
Neveu PJ; Borduas AG
Immunology; 1975 Feb; 28(2):315-22. PubMed ID: 47307
[TBL] [Abstract][Full Text] [Related]
29. Regulation of immunity to the azobenzenearsonate hapten.
Greene MI; Nelles MJ; Sy MS; Nisonoff A
Adv Immunol; 1982; 32():253-300. PubMed ID: 6214163
[No Abstract] [Full Text] [Related]
30. In vitro correlates of hapten-specific delayed hypersensitivity.
Hanna N; Ferraresi RW; Leskowitz S
Cell Immunol; 1973 Jul; 8(1):155-61. PubMed ID: 4730525
[No Abstract] [Full Text] [Related]
31. Delayed hypersensitivity to azobenzenearsonate amino acids conjugates. In vitro study of the specificity of the immune response by 3 H-thymidine incorporation into lymph node cells.
Nauciel C
Cell Immunol; 1972 Dec; 5(4):587-92. PubMed ID: 4640816
[No Abstract] [Full Text] [Related]
32. Presence of highly conserved idiotypic determinants in a family of antibodies that constitute an intrastrain cross-reactive idiotype.
Lamoyi E; Estess P; Capra JD; Nisonoff A
J Exp Med; 1980 Sep; 152(3):703-11. PubMed ID: 6157773
[TBL] [Abstract][Full Text] [Related]
33. Delayed hypersensitivity to mono-azobenzene-arsonate-N-acetyl-L-tyrosine. I. Induction of cellular sensitivity in the rat.
Sobel A; Degrand F; Wallon C; Galanaud P; Dormont J; Raynaud M
Biomedicine; 1975 Oct; 23(8):318-22. PubMed ID: 1231926
[TBL] [Abstract][Full Text] [Related]
34. Immunochemical study of antigenic specificity in delayed hypersensitivity. 3. Suppression of hapten-specific delayed hypersensitivity by conjugates of varying size.
Leskowitz S; Jones VE
J Immunol; 1965 Aug; 95(2):331-5. PubMed ID: 5838755
[No Abstract] [Full Text] [Related]
35. Hapten-specific help mediated by an anti-ABA T cell line.
Kojima A; Thomas WR; Mottram PL; Miller JF
Int Arch Allergy Appl Immunol; 1983; 72(4):299-302. PubMed ID: 6227564
[TBL] [Abstract][Full Text] [Related]
36. Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum.
Migliore-Samour D; Korontzis M; Jollès P
Immunol Commun; 1974; 3(6):593-603. PubMed ID: 4217774
[No Abstract] [Full Text] [Related]
37. Regulation of anti-hapten antibody response by chemically modified carrier antigen preferentially provoking delayed-type hypersensitivity. I. Possible T-T cell interaction in the suppression of antibody response.
Machida A; Kumazawa Y; Mizunoe K
Immunology; 1977 Aug; 33(2):199-207. PubMed ID: 305410
[TBL] [Abstract][Full Text] [Related]
38. Amino acid contribution to hapten specificity in delayed reaction to arsanilic acid conjugates.
Leskowitz S; Richerson HB; Schwartz HJ
Immunochemistry; 1970 Dec; 7(12):949-54. PubMed ID: 5503626
[No Abstract] [Full Text] [Related]
39. Sensitization to carrier antigens following delayed reactions to the hapten.
Goldman M; Leskowitz S
Int Arch Allergy Appl Immunol; 1970; 38(1):1-5. PubMed ID: 4189452
[No Abstract] [Full Text] [Related]
40. Hapten-carrier relationships.
Benacerraf B; Paul WE; Green I
Ann N Y Acad Sci; 1970 Feb; 169(1):93-104. PubMed ID: 4244326
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
